Chatbot-based Intervention to Promote Vaccine Acceptance in Varansi, India
NCT ID: NCT05994820
Last Updated: 2024-03-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2058 participants
INTERVENTIONAL
2023-09-26
2024-02-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Testing The Effectiveness Of Two Interventions To Reduce Vaccine Hesitancy Among Adolescents
NCT06155877
Khushi Baby (KB): Novel Mobile Health Solution for Vaccination Record Keeping in India
NCT02518178
Social Media-based Vaccine Confidence and Hesitancy Monitoring
NCT05442762
Communicating Human Papillomavirus Vaccine With Japanese Parents and Caregivers With Daughters Aged 12-18
NCT06347627
Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' Rotarix™ (Human Rotavirus Vaccine) in Indian Infants
NCT00938327
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
These participants receive no intervention. No chatbot messaging. Usual care.
No interventions assigned to this group
Vaccine Campaign
These participants will receive the Happy Baby Programme messages through a WhatsApp Chatbot. All messages will be narrowly focused on vaccine promotion.
Happy Baby Programme -Vaccine Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi.
Vaccine++ Campaign
These participants will receive the Happy Baby Programme messages through a WhatsApp Chatbot. All messages will promote vaccines in conjunction with other health-promotion activities (e.g. nutrition, breastfeeding, etc.).
Happy Baby Programme- Vaccine ++ Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi as part of a holistic healthy baby approach that includes nutrition and sanitation.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Happy Baby Programme -Vaccine Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi.
Happy Baby Programme- Vaccine ++ Campaign
The Happy Baby Programme is a WhatsApp based Chatbot designed to promote childhood vaccination in Hindi as part of a holistic healthy baby approach that includes nutrition and sanitation.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Reside in selected UUH neighborhood of Varanasi, India;
* Identify as a caregiver of a young child (\<2) OR be at least 5 months pregnant and due to giver birth during the study period;
* Child is registered with local community health workers and included on patient rosters for vaccination clinics (also known as Village Health Sanitation and Nutrition Days (VHSNDs));
* Have regular access to a phone with WhatsApp.
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Johns Hopkins Bloomberg School of Public Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Rajiv N Rimal, PhD
Role: PRINCIPAL_INVESTIGATOR
Johns Hopkins University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
D-COR (Development Corner) Consulting
Dwārka, New Delhi, India
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB00023512
Identifier Type: OTHER
Identifier Source: secondary_id
IRB00023512
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.